Kilitch Drugs to divest Ethiopian arm for $14 million
The divestment will enable capital reallocation towards higher-growth opportunities in India, debt repayment and expansion of core pharmaceutical business
Read the full story at source →
The divestment will enable capital reallocation towards higher-growth opportunities in India, debt repayment and expansion of core pharmaceutical business
Read the full story at source →
Post Comment